Rick Klausner, M.D.
Dr. Klausner is currently the founder and Chief Scientist of Altos Labs and founder and Chairman of Lyell Immunopharma, Inc. He is the President of the Milky Way Research Foundation and founder and Managing Partner of Milky Way Investments. He was the founder and Director of Juno Therapeutics and the founder and Director of GRAIL. He is the Chairman of Sonoma Biotherapeutics. Co-Founder and Chairman of Lifemine Therapeutics. He is the former Senior Vice President, Chief Medical Officer, and Chief Opportunity Officer of Illumina Corporation. Previously, he was Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the US National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development and a past president of the American Society of Clinical Investigation. He has served in senior advisory roles to the US, Norwegian, Qatari, and Indian governments.